1. GPCR activation mechanisms across classes and macro/microscales
- Author
-
Michel Bouvier, Franziska M. Heydenreich, Christian Munk, David E. Gloriam, M. Madan Babu, Albert J. Kooistra, Dmitry B. Veprintsev, and Alexander S. Hauser
- Subjects
0303 health sciences ,Drug discovery ,Protein Conformation ,Chemistry ,G protein ,Allosteric regulation ,Computational Biology ,SUPERFAMILY ,Computational biology ,Article ,Computational biology and bioinformatics ,Receptors, G-Protein-Coupled ,3. Good health ,Enzyme Activation ,03 medical and health sciences ,0302 clinical medicine ,Structural Biology ,Humans ,Databases, Protein ,Receptor ,Molecular Biology ,030217 neurology & neurosurgery ,Signal Transduction ,030304 developmental biology ,G protein-coupled receptor - Abstract
Two-thirds of human hormones and one-third of clinical drugs activate ~350 G-protein-coupled receptors (GPCR) belonging to four classes: A, B1, C and F. Whereas a model of activation has been described for class A, very little is known about the activation of the other classes, which differ by being activated by endogenous ligands bound mainly or entirely extracellularly. Here we show that, although they use the same structural scaffold and share several ‘helix macroswitches’, the GPCR classes differ in their ‘residue microswitch’ positions and contacts. We present molecular mechanistic maps of activation for each GPCR class and methods for contact analysis applicable for any functional determinants. This provides a superfamily residue-level rationale for conformational selection and allosteric communication by ligands and G proteins, laying the foundation for receptor-function studies and drugs with the desired modality., Comparative analysis of inactive/active-state structures reveals molecular mechanistic maps of activation of the major GPCR classes. The findings and new approaches lay the foundation for targeted receptor-function studies and drugs with desired modalities.
- Published
- 2021
- Full Text
- View/download PDF